share_log

HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $4.5 Price Target

HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $4.5 Price Target

HC Wainwright & Co.重申買入Unicycive Therapeutics,維持4.5美元的目標股價
Benzinga ·  2023/12/19 06:27

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price target.

HC Wainwright & Co. 分析師埃德·阿爾塞重申Unicycive Therapeutics(納斯達克股票代碼:UNCY)的買入並維持4.5美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論